PMC:7571312 / 19230-19450 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T57","span":{"begin":31,"end":35},"obj":"Disease"},{"id":"T58","span":{"begin":70,"end":74},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"that possessed weak reversible SARS CoV-1 3CLpro inhibition.\nTable 2 SARS CoV-1 3CLpro Inhibition Data for P3-Modified Acyloxymethylketone Inhibitors\na See the Experimental Section for details on assay methods; the val"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T58796","span":{"begin":151,"end":152},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"that possessed weak reversible SARS CoV-1 3CLpro inhibition.\nTable 2 SARS CoV-1 3CLpro Inhibition Data for P3-Modified Acyloxymethylketone Inhibitors\na See the Experimental Section for details on assay methods; the val"}

{"project":"LitCovid-sentences","denotations":[{"id":"T122","span":{"begin":61,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"that possessed weak reversible SARS CoV-1 3CLpro inhibition.\nTable 2 SARS CoV-1 3CLpro Inhibition Data for P3-Modified Acyloxymethylketone Inhibitors\na See the Experimental Section for details on assay methods; the val"}

{"project":"LitCovid-PubTator","denotations":[{"id":"509","span":{"begin":43,"end":48},"obj":"Gene"},{"id":"510","span":{"begin":31,"end":39},"obj":"Species"},{"id":"518","span":{"begin":70,"end":78},"obj":"Species"},{"id":"519","span":{"begin":120,"end":139},"obj":"Chemical"}],"attributes":[{"id":"A510","pred":"tao:has_database_id","subj":"510","obj":"Tax:694009"},{"id":"A518","pred":"tao:has_database_id","subj":"518","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"that possessed weak reversible SARS CoV-1 3CLpro inhibition.\nTable 2 SARS CoV-1 3CLpro Inhibition Data for P3-Modified Acyloxymethylketone Inhibitors\na See the Experimental Section for details on assay methods; the val"}